IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Jazz Pharmaceuticals builds $60-million manufacturing and development plant in Ireland

4:18 AM MST | February 11, 2014 | Natasha Alperowicz

Jazz Pharmaceuticals (Dublin), a specialty biopharmaceutical company, on Monday held a ground breaking ceremony for a €45–50 million ($60-68 million) manufacturing and development facility at Monksland, County Roscommon, Ireland. This manufacturing facility will be the first built by Jazz.     “This investment not only strengthens our international manufacturing capabilities but importantly represents our commitment to expanding our presence in Ireland. We are grateful for the partnership of Ireland’s Industrial Development...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa